Prevalence of specific antibody to hepatitis E virus in the general population of the community of Madrid, Spain
- 16 November 2011
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 84 (1), 71-74
- https://doi.org/10.1002/jmv.22270
Abstract
Hepatitis E virus (HEV) is an infectious agent causing hepatitis among humans. Although hepatitis E has been reported from many European countries, its incidence in Europe is largely unknown, and the prevalence of the HEV infection is also unknown for most countries of the region. Antibody to HEV (anti-HEV) was tested on 2,305 serum samples from the general population of the Community of Madrid (Spain) collected in the year 2008 among people aged 2–60 years. Total anti-HEV was tested by enzyme-immunoassay (EIA), and reactive samples were retested separately for anti-HEV IgG and IgM by recombinant immunoblot test (RIBT). Fifty samples (2.17%) displayed reactivity for total anti-HEV after EIA testing, and anti-HEV IgG was confirmed by RIBT in 25 (1.08%). The frequency of RIBT-confirmed anti-HEV ranged from 0.97% among the youngest to 3.61% among the oldest, and displayed a statistically significant trend to increasing with age. The rate of RIBT confirmation was also significantly higher among the individuals aged above 20 years old than among those younger of 21 years. HEV infection would be less frequent in the Community of Madrid than in Catalonia or the United Kingdom, and contact with HEV would be very uncommon among children and adolescents of the region. Confirmation of EIA-reactive samples by RIBT reduced the final numbers of anti-HEV testing as much as 50%, and some findings of this study suggest that such testing protocol would reflect better the real prevalence of anti-HEV in settings of low endemicity than the single testing by EIA. J. Med. Virol. 84:71–74, 2011.This publication has 17 references indexed in Scilit:
- Diagnosis of acute hepatitis E by antibody and molecular testing: A study on 277 suspected casesJournal of Clinical Virology, 2011
- Population Seroprevalence of Hepatitis E Virus Antibodies in Rural BangladeshThe American Journal of Tropical Medicine and Hygiene, 2009
- Transmission routes and risk factors for autochthonous hepatitis E virus infection in Europe: a systematic reviewEpidemiology and Infection, 2009
- Editorial Commentary:The Mystery of Hepatitis E Seroprevalence in Developed Countries: Is There Subclinical Infection due to Hepatitis E Virus?Clinical Infectious Diseases, 2008
- Prevalence of Hepatitis E Virus Infection in Children in the Northeast of SpainClinical and Vaccine Immunology, 2008
- Use of Serological Assays for Diagnosis of Hepatitis E Virus Genotype 1 and 3 Infections in a Setting of Low EndemicityClinical and Vaccine Immunology, 2007
- Community-Based Seroepidemiological Survey of Hepatitis E Virus Infection in Catalonia, SpainClinical and Vaccine Immunology, 2006
- Prevalencia de inmunidad frente a los virus de la hepatitis en gestantes del Área Sanitaria de GijónGastroenterología y Hepatología, 2004
- Hepatitis E Virus: Relevance in Blood Donors and Risk GroupsVox Sanguinis, 1999
- Prevalencia de las infecciones por virus de las hepatitis B, C, D y E en BoliviaRevista Panamericana de Salud Pública, 1999